High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Meta-analysis of Efficacy of Topotecan
- Status
- COMPLETED
- Phase
- N/A
Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study in Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations
- Status
- UNKNOWN
- Phase
- PHASE2
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2